Abeona Therapeutics (ABEO) News Today $5.64 0.00 (0.00%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$5.68 +0.04 (+0.62%) As of 07:40 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ABEO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Abeona Therapeutics (NASDAQ:ABEO) Shares Cross Below 50-Day Moving Average - What's Next?September 18 at 4:41 AM | marketbeat.comAbeona Therapeutics Inc. $ABEO Shares Acquired by Trexquant Investment LPSeptember 10, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Sells 1,210,732 Shares of Abeona Therapeutics Inc. $ABEOSeptember 9, 2025 | marketbeat.comShould You Invest in Abeona Therapeutics (ABEO)?September 8, 2025 | insidermonkey.comAbeona Therapeutics Inc. $ABEO Shares Bought by Newtyn Management LLCSeptember 7, 2025 | marketbeat.comAbeona Therapeutics Inc. Stock (ABEO) Opinions on Upcoming Revenue InitiationSeptember 5, 2025 | quiverquant.comQ683 Capital Management LLC Has $3.21 Million Holdings in Abeona Therapeutics Inc. $ABEOSeptember 4, 2025 | marketbeat.comWellington Management Group LLP Purchases 59,832 Shares of Abeona Therapeutics Inc. $ABEOSeptember 3, 2025 | marketbeat.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 2, 2025 | globenewswire.comWalleye Capital LLC Sells 402,944 Shares of Abeona Therapeutics Inc. $ABEOSeptember 2, 2025 | marketbeat.comAbeona Therapeutics® Announces Participation in Upcoming Investor ConferencesAugust 29, 2025 | globenewswire.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Given Consensus Rating of "Buy" by BrokeragesAugust 29, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Given Average Recommendation of "Buy" by AnalystsAugust 29, 2025 | marketbeat.comQ3 EPS Estimate for Abeona Therapeutics Increased by AnalystAugust 23, 2025 | marketbeat.comHC Wainwright Issues Negative Estimate for ABEO EarningsAugust 22, 2025 | marketbeat.comQ1 EPS Estimate for Abeona Therapeutics Lowered by AnalystAugust 21, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Q2 2025 Earnings Call TranscriptAugust 20, 2025 | msn.comAbeona Therapeutics (NASDAQ:ABEO) Given "Buy" Rating at HC WainwrightAugust 20, 2025 | marketbeat.comAbeona Therapeutics Inc. (ABEO) Q2 2025 Earnings Call TranscriptAugust 19, 2025 | seekingalpha.comABEO: First Patient Treatment with Zevaskyn Expected in 3Q25…August 18, 2025 | finance.yahoo.comAbeona Therapeutics (NASDAQ:ABEO) Releases Earnings Results, Beats Expectations By $2.10 EPSAugust 17, 2025 | marketbeat.comAbeona Therapeutics (NASDAQ:ABEO) Price Target Raised to $20.00 at OppenheimerAugust 17, 2025 | marketbeat.comAbeona Therapeutics: AAV204 Capsid Could Be Next Growth Prospect Beyond ZevaskynAugust 15, 2025 | seekingalpha.comAbeona Therapeutics Reports Strong Financial TurnaroundAugust 15, 2025 | msn.comAbeona Therapeutics price target raised to $20 from $19 at OppenheimerAugust 15, 2025 | msn.comAbeona Therapeutics expects cash to fund operations for over two yearsAugust 14, 2025 | msn.comAbeona Therapeutics reports Q2 EPS ($1.71) vs (26c) last yearAugust 14, 2025 | msn.comAbeona Therapeutics Shares Rise on Higher 2Q Net, Drug LaunchAugust 14, 2025 | marketwatch.comAbeona Therapeutics: Q2 Earnings SnapshotAugust 14, 2025 | chron.comAbeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate UpdatesAugust 14, 2025 | globenewswire.comAAV for the Hereditary Retinal Diseases Clinical Trial Pipeline Analysis Demonstrates 70+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses ...August 5, 2025 | finance.yahoo.comAbeona Therapeutics (ABEO) Projected to Post Earnings on MondayAugust 5, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Receives Average Rating of "Buy" from BrokeragesAugust 3, 2025 | marketbeat.comAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | globenewswire.comAbeona Therapeutics, AscellaHealth Partner for Commercialization of ZEVASKYN Gene TherapyAugust 1, 2025 | msn.comHow A 60-Year-Old Drug Developer Built A $4.4 Billion Biotech Treating ‘Butterfly Skin Disease’July 31, 2025 | forbes.comAscellaHealth HUB Partnership with Abeona Therapeutics® Supports Launch Success of Novel Cell-Based Gene Therapy and Access to Treatment for Rare Disease PatientsJuly 29, 2025 | globenewswire.comAbeona Therapeutics Inc News (ABEO) - Investing.comJuly 23, 2025 | investing.comAbeona Therapeutics Inc. (NASDAQ:ABEO) About To Shift From Loss To ProfitJuly 17, 2025 | finance.yahoo.comZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay AreaJuly 15, 2025 | tmcnet.comZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay AreaJuly 15, 2025 | globenewswire.comBio-Techne Corporation: Bio-Techne's Simple Western Technology Utilized in Recent FDA Approval of ZEVASKYN Cell-Based Gene TherapyJuly 14, 2025 | finanznachrichten.deAbeona Therapeutics' (ABEO) Buy Rating Reiterated at HC WainwrightJuly 14, 2025 | marketbeat.comBio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene TherapyJuly 14, 2025 | prnewswire.comFaith L. Charles Sells 10,738 Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO) StockJuly 11, 2025 | insidertrades.comInsider Selling: Abeona Therapeutics Inc. (NASDAQ:ABEO) Director Sells 10,738 Shares of StockJuly 10, 2025 | marketbeat.comAbeona Therapeutics Inc. (NASDAQ:ABEO) Director Sells $76,724.98 in StockJuly 10, 2025 | marketbeat.comInsider Selling: Abeona Therapeutics Inc. (NASDAQ:ABEO) Director Sells 13,093 Shares of StockJuly 10, 2025 | marketbeat.comInsider Selling: Abeona Therapeutics Inc. (NASDAQ:ABEO) SVP Sells 17,428 Shares of StockJuly 10, 2025 | marketbeat.comJoseph Walter Vazzano Sells 25,411 Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO) StockJuly 10, 2025 | marketbeat.com Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABEO Media Mentions By Week ABEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABEO News Sentiment▼1.160.63▲Average Medical News Sentiment ABEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABEO Articles This Week▼14▲ABEO Articles Average Week Get the Latest News and Ratings for ABEO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Abeona Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Amphastar Pharmaceuticals News Stoke Therapeutics News Tilray Brands News Evotec News Arcus Biosciences News Intellia Therapeutics News Tourmaline Bio News Pharvaris News Xeris Biopharma News Structure Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABEO) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
